2025-524210-28-00
Not yet recruiting
Phase 1
A Study to Track How the Healthy Male Participants Handles the New Oral Drug RO7795081 for Weight Management and Diabetes
F. Hoffmann-La Roche AG1 site in 1 country10 target enrollmentStarted: February 11, 2026Last updated:
Overview
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
- F. Hoffmann-La Roche AG
- Enrollment
- 10
- Locations
- 1
Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Sex
- Male
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Trial Information System - TISL
Scientific
F. Hoffmann-La Roche AG
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-068214972023-508371-36-00Pfizer Inc.6
Recruiting
Phase 1
A study in healthy men to test how well different doses of BI 3776528 are tolerated2024-515222-92-00Boehringer Ingelheim International GmbH118
Completed
Phase 1
A study in healthy men to test how well different doses of BI 3731579 are tolerated2023-510318-25-00Boehringer Ingelheim International GmbH64
Not yet recruiting
Phase 1
A study in healthy men to find out how different doses of BI 3009947 are tolerated and how different formulations or food influence how BI 3009947 is taken up into the blood2025-521095-66-00Boehringer Ingelheim International GmbH68
Completed
Phase 1/2
A study in two groups of healthy male adult participants to assess how much test medicine (SAR441566) is taken up, degraded and removed by the body and to assess the extent to which SAR441566 becomes available to the body when given by mouth2023-508030-33-00Sanofi-Aventis Recherche & Developpement13